Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Velcade (Bortezomib for Injection) Observational Study

Trial Profile

Velcade (Bortezomib for Injection) Observational Study

Phase of Trial: Phase IV

Latest Information Update: 12 Oct 2014

At a glance

  • Drugs Bortezomib (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Xian-Janssen
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 03 Oct 2012 Primary endpoints added as reported by ClinicalTrials.gov.
    • 05 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top